Pfizer will draw on the expertise of Citi analyst Andrew Baum when it comes to portfolio management and capital deployment, naming him chief strategy and innovation officer. The veteran biotech ...

The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most ...

Boehringer Ingelheim says it may have found the first therapy for diabetic macular ischaemia (DMI), a common and irreversible ...

The hedge fund says it wants to send a “strong and clear message” to the board at Novavax, reiterating the claim – first made a few weeks ago – that the company is “being hindered by an overly ...

Digital technology enables the creation of symmetric profiles of individuals' health structures. Pioneered by the likes of ...

The vaccine – developed by researchers at the University of Florida (UF) in the US – is based on mRNA taken from the ...

Astellas bought Xyphos in 2019 in a $500 million-plus deal that included an upfront payment of $120 million, putting the ...

Boehringer Ingelheim, GSK, Novartis, Teva, and Covis Pharma have been taken to task for asthma and COPD inhalers, while ...

Zepbound brought in first-quarter sales of $517 million, ahead of analyst expectations, while Mounjaro added $1.8 billion, ...

The AI-Airlock regulatory sandbox will bring together the NHS, regulatory authorities, and approved bodies – organisations ...

Jacobio Pharma has reported the results of its pivotal Chinese study of KRAS G12C inhibitor glecirasib, with a safety profile ...

Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for ...